The FSA Spy market buzz – 4 April 2025
BNY Mellon IM’s conversion; Elusive libertarian investing dream; Eastspring and Vontobel on tariffs; Wisdom of Larry Fink; Has the EU finally seen sense? Price of admission and much more.
HEAD-TO-HEAD: JP Morgan AM versus UBS AM
FSA compares two highly-rated China equity funds: the JP Morgan China Fund and the UBS China Opportunity Fund.
Conclusion
Both the JP Morgan and UBS funds receive a five-star Morningstar rating and an analyst rating of Silver.
Morningstar’s star rating looks at historically-adjusted performance and the analyst rating is based on forward-looking analysis.
Liang does not prefer one fund over the other, given that the funds have the same analyst ratings.
“We have confidence in both strategies equally,” she said.
However, she believes that given their differences, the funds may appeal to different kinds of investors.
“Investors who want a more predictable performance may opt for the JP Morgan fund, given that it is more benchmark-aware,” she said.
“Those with a higher risk appetite may consider the UBS fund, as it is more benchmark-agnostic.”
However, Liang noted that investors who are looking at the UBS fund should consider its fund size, which is nearly $10bn.
“The fund has attracted a lot of inflows in the past few years. We always have concerns over the capacity of a strategy, but that said, we haven’t seen the manager compromise his core investment process when managing the fund.”
Related Stories
Promoted Content
-
Exciting opportunities in AI & Robotics outside of traditional tech
-
Investment Ideas for 2021: Explore the untapped potential in China Small Companies
-
China bonds: plugging the yield gap
-
Conditions in the high yield market
-
The year of living dangerously for income investors
-
Turning environmental hopes into investment reality
-
Despite headwinds, ESG continues to perform
-
Tech WELLcovered | Work reimagined
-
Don’t get left behind in fixed income
-
Driving decarbonisation: how to access new forms of alpha
